← Back to Clinical Trials
Recruiting NCT05024981

NCT05024981 Videographic Feedback and Walk Rehabilitation in Post-Cerebrovascular Accident

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05024981
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire de Nice
Condition Cerebrovascular Accident
Study Type INTERVENTIONAL
Enrollment 64 participants
Start Date 2022-03-04
Primary Completion 2027-01-04

Trial Parameters

Condition Cerebrovascular Accident
Sponsor Centre Hospitalier Universitaire de Nice
Study Type INTERVENTIONAL
Phase N/A
Enrollment 64
Sex ALL
Min Age 70 Years
Max Age N/A
Start Date 2022-03-04
Completion 2027-01-04
Interventions
Videographic feedbackClassic reeducation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Cerebrovascular Accident affects the majority of the elderly population and its frequency is constantly increasing. The resulting deficits are numerous and lead in particular to an alteration in the quality of walking and autonomy. Numerous rehabilitation techniques have been described. In practice, correction instructions are often given by the therapist while the motor activity is being performed. Walking is a complex activity, as is the processing of dual-task information in elderly stroke patients. It therefore appears interesting to separate the time of motor realization and that of correction instructions. Investigators therefore propose firstly to film the patient during the performance of a walking activity and then, secondly, to analyse the video with the patient, which thus represents a source of delayed feedback. The main objective of the study is to observe the effects of this practice on walking speed. Investigators are comparing two groups of patients: the control group receiving conventional rehabilitation and the experimental group receiving conventional rehabilitation plus sessions with the video tool. They expect to observe a greater improvement in walking speed in the experimental group.

Eligibility Criteria

Inclusion Criteria: * Hospitalization for a first episode of Cerebrovascular Accident less than six months old, or nth stroke less than six months old, with no previous sequelae; * Able to walk at least 10m without stopping, with or without technical assistance, but without human assistance, under supervision; Exclusion Criteria: * Palliative or life-threatening situation; * A patient whose guardian or trustee is not readily available to provide information about the patient * Neuro-cognitive disorder that prevents understanding of instructions, as determined by the clinician; * Severe speech or language disorder that prevents the protocol from being carried out correctly; * Hemineglect; * Any previously known pathology altering the gait pattern, at the clinician's discretion (recent neurological, traumatological or orthopaedic pathologies, etc.); * Visual disorder preventing viewing of the video; * Hearing disorder preventing comprehension.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology